NVCR

NovoCure Limited is a healthcare company operating in the medical devices industry. The company has a significant market presence with a market capitalization of $1.54 billion and revenue of $642.27 million (TTM). It employs 1488 individuals. From a financial perspective, NovoCure Limited's profitability metrics indicate substantial losses. The company reports an operating margin of -21.5% and a profit margin of -27.7%. Its return on equity is -50.6%, while the return on assets stands at -8.3%. Notably, the company has a significant amount of debt with $797.94 million in liabilities, but also possesses substantial cash reserves totaling $1.03 billion. Valuation metrics for NovoCure Limited indicate a mixed picture. The forward P/E ratio is -9.32, and the EV/EBITDA ratio stands at -7.75. However, the price to book ratio of 4.52 suggests that the company's stock value may be relatively high compared to its book value. Revenue growth has been steady with a YoY increase of 7.8%, but earnings growth is not available due to reported losses.